Intracerebral infusion of thrombin as a cause of brain edema.
Purified thrombin from an exogenous source is a hemostatic agent commonly used in neurosurgical procedures. The toxicity of thrombin in the brain, however, has not been examined. This study was performed to assess the effect of thrombin on brain parenchyma, using the formation of brain edema as an indicator of injury. Ten microliters of test solution was infused stereotactically into the right basal ganglia of rats. The animals were sacrificed 24 hours later, and the extent of brain edema and ion content were measured. Concentrations of human thrombin as low as 1 U/microliter resulted in a significant increase in brain water content. Rats receiving 10 U/microliters had a mortality rate of 33% compared to no mortality in the groups receiving smaller doses. Thrombin-induced brain edema was inhibited by a specific and potent thrombin inhibitor, hirudin. A medical grade of bovine thrombin commonly used in surgery also caused brain edema when injected at a concentration of 2 U/microliters. Edema formation was prevented by another highly specific thrombin inhibitor, N alpha-(2-Naphthalenesulfonylglycyl)-4-DL-phenylalaninepiperidid e (alpha-NAPAP). Thrombin-induced brain edema was accompanied by increases in brain sodium and chloride contents and a decrease in brain potassium content. Changes in brain ions were inhibited by both hirudin and alpha-NAPAP, corresponding to the inhibition of brain water accumulation. This study shows that thrombin causes brain edema when infused into the brain at concentrations as low as 1 U/microliter, an amount within the range of concentrations used for topical hemostasis in neurosurgery.
D000818:Animals; D001921:Brain / Q000378:metabolism; D001929:Brain Edema / Q000139:chemically induced* / Q000378:metabolism; D002712:Chlorides / Q000378:metabolism; D004151:Dipeptides / Q000494:pharmacology; D006629:Hirudins / Q000494:pharmacology; D007278:Injections, Spinal; D008279:Magnetic Resonance Imaging; D008297:Male; D011188:Potassium / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000378:metabolism; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000633:toxicity*; D014867:Water
D002712:Chlorides; D004151:Dipeptides; D006629:Hirudins; D011480:Protease Inhibitors; D014867:Water; C028249:N(alpha)-phosphorylalanylproline; D012964:Sodium; D013917:Thrombin; D011188:Potassium